Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 AUD | +1.79% | -6.56% | +18.75% |
Apr. 02 | Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8% | MT |
Mar. 12 | Artrya Gears Up for US Launch After Tanner Health System Partnership | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.28M 25.82M |
---|---|---|---|---|---|
Net income 2022 | -17M -25.4M | Net income 2023 | -11M -16.44M | EV / Sales 2022 | - |
Net cash position 2022 | 34.19M 51.09M | Net cash position 2023 | 19.19M 28.68M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.51
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.29% |
1 day | +1.79% | ||
1 week | -6.56% | ||
Current month | -13.64% | ||
1 month | -1.72% | ||
3 months | +1.79% | ||
6 months | +35.71% | ||
Current year | +18.75% |
Managers | Title | Age | Since |
---|---|---|---|
Mathew Regan
CEO | Chief Executive Officer | - | 23-03-26 |
Mark Wainwright
DFI | Director of Finance/CFO | - | 21-08-31 |
Jacob Agris
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacque Sokolov
BRD | Director/Board Member | 69 | 22-07-31 |
Chairman | 70 | 21-01-31 | |
Catherine Hill
BRD | Director/Board Member | 65 | 23-02-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.285 | +1.79% | 8,660 |
24-05-16 | 0.28 | 0.00% | 65,268 |
24-05-15 | 0.28 | -6.67% | 46,715 |
24-05-14 | 0.3 | -1.64% | 14,102 |
24-05-13 | 0.305 | 0.00% | 16,652 |
Delayed Quote Australian S.E., May 16, 2024 at 08:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+18.75% | 14.99M | |
-16.99% | 8.55B | |
+65.23% | 4.24B | |
-1.63% | 2.54B | |
-41.76% | 2.35B | |
-8.53% | 1.89B | |
-19.29% | 1.55B | |
-39.61% | 1.23B | |
+9.54% | 1.13B | |
+19.57% | 955M |
- Stock Market
- Equities
- AYA Stock